ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CELC vs ACHC // OPERATING MARGIN

Celcuity Inc. (NASDAQ) VS. Acadia Healthcare Company Inc. (NASDAQ) • 15-METRIC TALLY: CELC 2 — ACHC 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CELC VS. ACHC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CELC ACHC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -24.80% -10.20 ACHC /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -4.53% -16.04% +11.51 CELC /fcf-yield <GO>
Operating Margin ACTIVE — -40.60% — TIE /operating-margins <GO>
Net Profit Margin — -33.30% — TIE /net-margins <GO>
Revenue Growth (YoY) — 5.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.45 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 5/9 -3.00 ACHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.3 50.9 -1.60 ACHC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.07 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 21.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.38B $2.79B $593.4M CELC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CELC REV ACHC REV CELC GROSS % ACHC GROSS % CELC FCF ACHC FCF
FY 2025 $482.1M $3.31B — — -$153.5M -$439.9M
FY 2024 $317.1M $3.15B — — -$83.7M -$560.7M
FY 2023 $185.4M $2.93B — — -$53.8M $330.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CELC // BETA —
ACHC // BETA 1.07